Aug 8 (Reuters) - Clayton, Dubilier & Rice (CD&R) is close to raising $23 billion for its new flagship buyout fund, overshooting its initial target by $3 billion to defy an industry-wide slump in ...

Paris, February 19, 2025. Following completion of the required social and corporate procedures, Sanofi and CD&R announce today they have signed the share purchase agreement in relation to the sale ...

Sanofi announces today the closing of the sale to CD&R of a 50.0% controlling stake of its consumer healthcare business Opella. Sanofi retains a significant shareholding of Opella with a 48.2% stake.

PARIS, Oct 21 (Reuters) - French drugmaker Sanofi (SASY.PA), opens new tab said on Monday it had entered exclusive talks to sell a 50% controlling stake in its consumer health business Opella to U ...

MURRAY, Utah, Nov. 19, 2024 (GLOBE NEWSWIRE) -- R1 RCM Inc. (“R1”), a leader in automating revenue management for healthcare providers, today announced that investment funds affiliated with ...

April 2 (Reuters) - U.S. private equity firm Clayton Dubilier & Rice (CD&R) said on Tuesday it had agreed to acquire a majority ownership position in information technology provider Presidio from ...

The investment is strategic for CD&R and not a prelude to a takeover of Pegasystems, said one of the people, asking not to be identified because the matter is private. Terms aren’t finalized and ...

Aug 1 (Reuters) - R1 RCM (RCM.O), opens new tab said on Thursday private-equity firms TowerBrook Capital Partners and Clayton, Dubilier & Rice (CD&R) would acquire the healthcare technology ...

Mosaic Health combines the strengths of apree health and Millennium Physician Group. That CD&R and Elevance Health would partner on primary care was announced in April, and the two said Mosaic ...

Aug 8 (Reuters) - Clayton, Dubilier & Rice (CD&R) is close to raising $23 billion for its new flagship buyout fund, overshooting its initial target by $3 billion to defy an industry-wide slump in ...